ENDRA Life Sciences (NDRA) Change in Cash (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Change in Cash of -$405903.0 for Q1 2026, up 65.15% year-over-year from -$245783.2 in Q1 2025, and down 1181.58% quarter-over-quarter from -$31672.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Change in Cash (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Change in Cash data on file, last reported at -$405903.0 in Q1 2026.
- Change in Cash for Q1 2026 came in at -$405903.0, up 65.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.7 million (down 283.67% YoY), and the FY2025 annual result was -$2.5 million, down 723.68% from the prior year.
- Change in Cash retreated to -$405903.0 in Q1 2026 per NDRA's latest filing, from -$31672.0 in the prior quarter.
- Over five years, Change in Cash peaked at $5.3 million in Q2 2024 and troughed at -$3.3 million in Q3 2022.
- A 5-year average of -$535592.5 and a median of -$1.2 million in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2024: Change in Cash surged 248.27% in 2022, then slumped 202.76% in 2024.
- A 5-year view of Change in Cash shows it stood at -$3.1 million in 2022, then soared by 83.99% to -$500629.0 in 2023, then tumbled by 202.76% to -$1.5 million in 2024, then soared by 97.91% to -$31672.0 in 2025, then tumbled by 1181.58% to -$405903.0 in 2026.
- Business Quant data shows NDRA's Change in Cash at -$405903.0 in Q1 2026, -$31672.0 in Q4 2025, and -$1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -126.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -6.60 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.09 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 20.46 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 49.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 11.79 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -33.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -329.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -6.31 Mn |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - | -405,903.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -405,903.00 |
| Dec 31, 2025 | -31,672.00 |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -256,300.00 |
| Mar 31, 2025 | -1.16 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Mar 31, 2024 | -1.70 Mn |
| Dec 31, 2023 | -500,629.00 |
| Sep 30, 2023 | -1.48 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Mar 31, 2023 | -2.53 Mn |
| Dec 31, 2022 | -3.13 Mn |
| Sep 30, 2022 | -3.26 Mn |
| Jun 30, 2022 | 4.15 Mn |
| Mar 31, 2022 | -2.33 Mn |
| Dec 31, 2021 | -2.33 Mn |
| Sep 30, 2021 | -2.25 Mn |
| Jun 30, 2021 | -2.80 Mn |